Board Meeting7 Aug 2026, 01:13 pm
Vivanza Biosciences Declares Unaudited Q1 FY27 Results
AI Summary
Vivanza Biosciences Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, along with the limited review report, during a meeting held on August 7, 2026. The company also noted disclosures of interest from directors and confirmations of independence from independent directors as per regulatory requirements. The meeting commenced at 12:45 PM and concluded at 1:00 PM.
Key Highlights
- Unaudited standalone and consolidated financial results declared.
- Results are for the quarter ended June 30, 2026.
- Board meeting held on August 7, 2026, approved the results.
- Limited review report also approved.
- Director disclosures and independence confirmations noted.
Price Impact
More from VIVANZA